| POR-GH (n = 52) | POR-C (n = 53) | Non-POR (n = 58) |
---|---|---|---|
rFSH doses (IU) a,b | 2491.46 ± 996.47 | 2499.87 ± 1345.16 | 1875.09 ± 467.39 |
rFSH duration (d) a,b | 8.93 ± 2.57 | 8.97 ± 4.11 | 10.65 ± 1.65 |
E2 on trigger day (pg/mL) a,b | 985.13 ± 348.44 | 887.85 ± 372.21 | 1956.10 ± 558.48 |
Endometrial thickness (mm) b,c | 9.65 ± 1.84 | 8.61 ± 1.23 | 10.33 ± 1.93 |
Oocytes retrieved a,b | 3.71 ± 2.50 | 3.24 ± 2.56 | 12.51 ± 6.81 |
MII oocytes a,b | 3.18 ± 1.78 | 2.87 ± 1.89 | 9.95 ± 4.28 |
Fertilized oocytes (2PN) a,b | 2.36 ± 1.86 | 2.02 ± 1.21 | 7.04 ± 4.29 |
Cleaved embryos a,b,c | 2.31 ± 1.81 | 1.73 ± 1.03 | 5.38 ± 3.62 |
Higher-quality embryos a,b,c | 1.26 ± 0.65 | 0.72 ± 0.56 | 3.34 ± 2.78 |
Oocyte maturation rate (%) | 82.38% (159/193) | 83.02% (132/159) | 79.48% (577/726) |
Oocyte fertilization rate | 74.21% (118/159) | 70.45% (93/132) | 70.71% (408/577) |
Embryo formation rate a,c | 95.76% (113/118) | 83.87% (78/93) | 76.47% (312/408) |
Higher-quality embryo formation rate b,c | 52.54% (62/118) | 35.48% (33/93) | 47.55% (194/408) |
No. ET | 1.58 ± 0.51 | 1.59 ± 0.48 | 1.43 ± 0.50 |
Excluded cycle rate (%) b | 5.77% (3/52) | 15.09% (8/53) | 0/58 |
Implantation rate (%) b,c | 28.21% (22/78) | 9.72% (7/72) | 43.37% (36/83) |
Clinical pregnancy rate (%) b,c | 38.77% (19/49) | 13.33% (6/45) | 53.44% (31/58) |
Miscarriage rate (%) | 21.05% (4/19) | 33.33% (2/6) | 6.45% (2/31) |
Multiple pregnancy rate (%) | 15.78% (3/19) | 16.67% (1/6) | 16.13% (5/31) |
In FF | |||
 MDA (nmol/mL) a,b | 2.27 ± 0.69 | 3.02 ± 1.10 | 1.33 ± 0.67 |
 SOD (U/mgprot) a,b | 12.99 ± 2.32 | 11.21 ± 1.71 | 14.76 ± 1.93 |
 TAC (mmol Trolox Equiv./L) a,b,c | 0.59 ± 0.13 | 0.42 ± 0.16 | 0.71 ± 0.11 |
 TOS (μmol H2O2 Equiv./L) a,b,c | 8.06 ± 1.19 | 10.14 ± 4.86 | 5.67 ± 1.09 |
 OSI a,b,c | 16.49 ± 8.19 | 23.87 ± 10.13 | 8.16 ± 1.86 |